PS
GILD icon

Principal Securities’s Gilead Sciences GILD Stock Holding History

Principal Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5M Buy
35,653
+6,367
+22% +$839K 0.05% 311
2026
Q1 		$4.08M Buy
29,286
+4,337
+17% +$607K 0.06% 307
2025
Q4 		$3.06M Buy
24,949
+4,615
+23% +$561K 0.05% 342
2025
Q3 		$2.26M Buy
20,334
+1,094
+6% +$124K 0.04% 415
2025
Q2 		$2.13M Buy
19,240
+4,802
+33% +$511K 0.04% 391
2025
Q1 		$1.33M Buy
14,438
+34
+0.2% +$3.51K 0.03% 462
2024
Q4 		$1.33M Buy
14,404
+4,468
+45% +$402K 0.03% 462
2024
Q3 		$833K Buy
9,936
+1,722
+21% +$131K 0.02% 589
2024
Q2 		$564K Buy
8,214
+1,262
+18% +$84.2K 0.02% 662
2024
Q1 		$509K Buy
6,952
+25
+0.4% +$1.92K 0.02% 658
2023
Q4 		$561K Buy
+6,927
New +$539K 0.02% 555

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principal Securities's GILD Position: Q2 2026 in Review

Principal Securities increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $839K and bringing the position to 35,653 shares worth $4.5M. The position accounts for 0.05% of the portfolio, ranked #311.

Principal Securities first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Principal Securities held 35,653 shares of Gilead Sciences worth $4.5M as of Q2 2026.
  • Principal Securities bought 6,367 Gilead Sciences shares in Q2 2026, an estimated $839K.
  • Gilead Sciences made up 0.05% of Principal Securities's portfolio in Q2 2026, its #311 holding.
  • Principal Securities first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.